Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term breast-cancer cells. Found 10 abstracts

Betancourt A, Mobley JA, Wang J, Jenkins S, Chen DQ, Kojima K, Russo J, Lamartiniere CA. Alterations in the Rat Serum Proteome Induced by Prepubertal Exposure to Bisphenol A and Genistein. Journal of Proteome Research. 2014 Mar;13(3):1502-14.   PMCID: PMC 3993963
Cukierman E, Bassi DE. The mesenchymal tumor microenvironment A drug-resistant niche. Cell Adhesion & Migration. 2012 May;6(3):285-96.   PMCID: PMC3427243
Delorme-Walker VD, Peterson JR, Chernoff J, Waterman CM, Danuser G, DerMardirossian C, Bokoch GM. Pak1 regulates focal adhesion strength, myosin IIA distribution, and actin dynamics to optimize cell migration. Journal of Cell Biology. 2011 Jun;193(7):1289-303.   PMCID: PMC3216326
Wargon V, Fernandez SV, Goin M, Giulianelli S, Russo J, Lanari C. Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas. Breast Cancer Research and Treatment. 2011 Apr;126(2):319-32.   PMCID: not NIH funded
Natsuizaka M, Ohashi S, Wong GS, Ahmadi A, Kalman RA, Budo D, Klein-Szanto AJ, Herlyn M, Diehl JA, Nakagawa H. Insulin-like growth factor-binding protein-3 promotes transforming growth factor-beta 1-mediated epithelial-to-mesenchymal transition and motility in transformed human esophageal cells. Carcinogenesis. 2010 Aug;31(8):1344-53.   PMCID: PMCID: PMC2915630 [Available on 2011/8/1]
Tikhmyanova N, Little JL, Golemis EA. CAS proteins in normal and pathological cell growth control. Cellular and Molecular Life Sciences. 2010 Apr;67(7):1025-48.   PMCID: PMC2836406 (Available on 2011/4/1)
Dupart JJ, Trent JC, Lee HY, Hess KR, Godwin AK, Taguchi T, Zhang W. Insulin-like growth factor binding protein-3 has dual effects on gastrointestinal stromal tumor cell viability and sensitivity to the anti-tumor effects of imatinib mesylate in vitro - art. no. 99. Molecular Cancer. 2009 Nov;8:99.   PMCID: PMC2780392
Abdelrahim M, Ariazi E, Kim K, Khan S, Barhoumi R, Burghardt R, Liu SX, Hill D, Finnell R, Wlodarczyk B, Jordan VC, Safe S. 3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha. Cancer Research. 2006 Feb;66(4):2459-67.
Nagar S, Walther S, Blanchard RL. Sulfotransferase (SULT) 1A1 polymorphic variants*1,*2, and*3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation. MOLECULAR PHARMACOLOGY. 2006 Jun;69(6):2084-92.
Katsetos CD, Stadnicka I, Boyd JC, Ehya H, Zheng S, Soprano CM, Cooper HS, Patchefsky AS, Soprano DR, Soprano KJ. Cellular distribution of retinoic acid receptor alpha protein in serous adenocarcinomas of ovarian, tubal, and peritoneal origin - Comparison with estrogen receptor status. American Journal of Pathology. 1998 Aug;153(2):469-80.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term breast-cancer cells

breast-cancer cells expression epithelial-cells gene-expression factor binding-protein-3 living cells x receptor carcinogenesis hmg-coa reductase dependent tyrosine phosphorylation serum dietary flavonoids mcf-7 cells statistical-model tumor-growth therapeutic strategies human liver carcinoma-cells nucleotide exchange factor meat intake lines tyrosine kinase inhibitor endothelial f-actin database search polycyclic aromatic-hydrocarbons crk-associated substrate acute lymphoblastic-leukemia proliferation pharmacogenetics dose imatinib beta receptor medroxyprogesterone acetate intestinal epithelial-cells phosphatase ptp-pest genotype BPA hematopoietic progenitor cells cpg island endocrine treatment growth-factor tissue hepa 1c1c7 cells multiple-myeloma cells p21-activated kinase dna methylation ductal carcinomas heterocyclic amines minimal residual disease tumor-stromal interactions tumor microenvironment-stromal-induced drug resistance-extracellular matrix-tumor-associated or carcinoma-associated fibroblasts-matrix-induced drug resistance-mesenchymal stroma p53 beta tgf-beta sensitivity pancreatic-cancer leading-edge growth risk adhesion-mediated drug light-chain kinase ah-responsiveness hela-cells apoptotic rat-1 cells prognostic-factors proteomics tumor-suppressor gene proteins gene BCAR1 CAS-NEDD9-Scaffold-Cancer-Invasion-Metastasis-Mitosis recruitment focal adhesion kinase growth- apoptosis induction carcinoma igfbp-3 bone-marrow microenvironment e-cadherin sp proteins cross-talk Hormone resistance Mammary carcinomas-Progesterone receptors-DNA-methylation-DNMT inhibitors lung-cancer genistein independent mechanisms fluorescent speckle microscopy tandem mass-spectrometry protrusion Oncology factor receptor overexpression genetic polymorphisms Pharmacology & Pharmacy estradiol inhibition estrogen-receptor matrix adhesions differentiation er-alpha human t-cells mammary-glands
Last updated on Wednesday, February 05, 2020